Brepocitinib is a potential first-in-class dual, selective inhibitor of TYK2 and JAK1; in all five placebo-controlled studies completed to date,…
PARIS, FRANCE / ACCESSWIRE / June 28, 2022 / Pharnext SA (FR0011191287 - ALPHA) (the "Company"), an advanced late-clinical stage…
VANCOUVER, BC / ACCESSWIRE / June 27, 2022 / Verisante Technology Inc. (NEX:VER.H) (the "Company") announces that further to the…
New study by Protiviti and ISACA underscores security risks looming large in today's dynamic threat landscape MENLO PARK, Calif., June…
Under Clearlake's ownership, Brightly transformed into a leading cloud-based asset management software platform with a broad suite of products solving…
ELMAU, Germany, June 27, 2022 /CNW/ - Canada is committed to standing in unity to support the government and people of…
Cloud Assurance Certified technologies must undergo the rigorous compliance, security, and data integrity assessment by USDM Life Sciences and demonstrate…
RECOGNIZED FOR ITS SIGNIFICANT ORGANIC REVENUE GROWTH, STRENGTHENED PROCESS AUTOMATION, AND DELIVERY CAPABILITIES DALLAS, June 27, 2022 /PRNewswire/ -- Access…
SAN FRANCISCO, June 27, 2022 /PRNewswire/ -- A new market study published by Global Industry Analysts Inc., (GIA) the premier…
SEATTLE, June 27, 2022 /PRNewswire/ -- Arzeda, the industry-leading Protein Design Company™, announced today that it is collaborating with W.…